Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 4Breast Neoplasms 3Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Toxemia 1Stomach Neoplasms 1Sarcoma 1Rhabdomyosarcoma 1Rectal Neoplasms 1Primary Ovarian Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Myocarditis 1Muscle Weakness 1Melanoma 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Diabetes, Gestational 1Colonic Neoplasms 1Cardiovascular Diseases 1Carcinoma, Neuroendocrine 1Carcinoma in Situ 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Specimen Handling 4Gemcitabine 4fludarabine 3aldesleukin 3Radiosurgery 3Oxaliplatin 3Fluorouracil 3Endoscopic Mucosal Resection 3Cyclophosphamide 3Cetuximab 3Bevacizumab 3130-nm albumin-bound paclitaxel 3Tomography, X-Ray Computed 2Surveys and Questionnaires 2Sunitinib 2Pemetrexed 2IDRX-42 2Folfox protocol 2Endoscopy, Digestive System 2Biopsy 2trastuzumab deruxtecan 1tislelizumab 1sodium thiosulfate 1sodium propionate 1semaglutide 1s-formylglutathione hydrolase 1repotrectinib 1regorafenib 1plecanatide 1pembrolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Positron-Emission Tomography × 90 days × Clear all
NCT03745326 2026-05-19

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
5 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡